These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32760643)

  • 1. Differential diagnostic value of
    Li X; Wu N; Zhang W; Liu Y; Ming Y
    J Bone Oncol; 2020 Oct; 24():100302. PubMed ID: 32760643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Performances in Lesions and Radiotracer of
    Deng C; Han D; Zhang X; Lv Z; Li D
    Curr Med Imaging; 2023; 19(7):713-719. PubMed ID: 35578864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative assessment of osteoblastic, osteolytic, and mixed lytic-sclerotic bone lesions on fluorodeoxyglucose positron emission tomography/computed tomography and bone scintigraphy.
    Gurkan G; Sarikaya I; Sarikaya A
    World J Nucl Med; 2019; 18(2):132-136. PubMed ID: 31040743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients.
    Lim CH; Ahn TR; Moon SH; Cho YS; Choi JY; Kim BT; Lee KH
    Eur Radiol; 2019 Apr; 29(4):1903-1911. PubMed ID: 30315418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.
    Choi HS; Yoo IeR; Park HL; Choi EK; Kim SH; Lee WH
    Clin Imaging; 2014; 38(2):109-14. PubMed ID: 24361174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential Diagnostic Value of
    Zheng QZ; Su JM; Li XL; Chen ZJ; Wang SZ; Zeng Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1267-1271. PubMed ID: 32798410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
    Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
    Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
    Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
    BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.
    Uchida K; Nakajima H; Miyazaki T; Tsuchida T; Hirai T; Sugita D; Watanabe S; Takeura N; Yoshida A; Okazawa H; Baba H
    Asian Spine J; 2013 Jun; 7(2):96-103. PubMed ID: 23741546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Relative Diagnostic Performance of [
    Wu J; Wang Y; Liao T; Rao Z; Gong W; Ou L; Chen Y; Zhang C
    Front Oncol; 2021; 11():737827. PubMed ID: 34604078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.
    Morita M; Higuchi T; Achmad A; Tokue A; Arisaka Y; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1672-81. PubMed ID: 24006150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple metabolic parameters and visual assessment of
    Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
    Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of
    Luo ZH; Qi WL; Jin AF; Liao FX; Liu Q; Zeng QY
    Front Oncol; 2022; 12():1068055. PubMed ID: 36530987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-time point
    Parghane RV; Basu S
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    J Comput Assist Tomogr; 2007; 31(5):812-9. PubMed ID: 17895798
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.